{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:51:28Z","timestamp":1792036288250,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["200110"],"award-info":[{"award-number":["200110"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["200110"],"award-info":[{"award-number":["200110"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["200110"],"award-info":[{"award-number":["200110"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["200110"],"award-info":[{"award-number":["200110"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["200110"],"award-info":[{"award-number":["200110"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10072-022-06362-8","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T02:03:39Z","timestamp":1661825019000},"page":"6839-6846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Occurrence of malignant diseases in patients with multiple sclerosis: population-based MS Registry data"],"prefix":"10.1007","volume":"43","author":[{"given":"Gorica","family":"Maric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Pekmezovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarlota","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Tamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Veselinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Budimkic Stefanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksa","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4516-3458","authenticated-orcid":false,"given":"Jelena","family":"Drulovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"6362_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1177\/1352458520968811","volume":"26","author":"T Coetzee","year":"2020","unstructured":"Coetzee T, Thompson AJ (2020) Atlas of MS 2020: Informing global policy change. Mult Scler 26:1807\u20131808. https:\/\/doi.org\/10.1177\/1352458520968811","journal-title":"Mult Scler"},{"key":"6362_CR2","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1177\/1352458518809326","volume":"25","author":"J Hobart","year":"2019","unstructured":"Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Hor\u00e1kov\u00e1 D, Lebrun-Fr\u00e9nay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, S\u00e1 MJ, S\u00eerbu CA, Skromne E, Torkildsen \u00d8, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G (2019) International consensus on quality standards for brain health-focused care in multiple sclerosis. Mult Scler 25:1809\u20131818. https:\/\/doi.org\/10.1177\/1352458518809326","journal-title":"Mult Scler"},{"key":"6362_CR3","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1212\/WNL.0000000000011219","volume":"96","author":"RA Marrie","year":"2021","unstructured":"Marrie RA, Maxwell C, Mahar A, Ekuma O, McClintock C, Seitz D, Webber C, Groome PA (2021) Cancer incidence and mortality rates in multiple sclerosis: a matched cohort study. Neurology 96:e50\u2013e512. https:\/\/doi.org\/10.1212\/WNL.0000000000011219","journal-title":"Neurology"},{"key":"6362_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1212\/WNL.0000000000001718","volume":"85","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Elliott L, Marriott J, Cossoy M, Blanchard J, Leung S, Yu N (2015) Effect of comorbidity on mortality in multiple sclerosis. Neurology 85:240\u2013247. https:\/\/doi.org\/10.1212\/WNL.0000000000001718","journal-title":"Neurology"},{"key":"6362_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1370\/afm.983","volume":"7","author":"JM Valderas","year":"2009","unstructured":"Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M (2009) Defining comorbidity: implications for understanding health and health services. Ann Fam Med 7:357\u2013363. https:\/\/doi.org\/10.1370\/afm.983","journal-title":"Ann Fam Med"},{"key":"6362_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Cohen J, Stuve O, Trojano M, S\u00f8rensen PS, Reingold S, Cutter G, Reider N (2015) A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler 21:263\u2013281. https:\/\/doi.org\/10.1177\/1352458514564491","journal-title":"Mult Scler"},{"key":"6362_CR7","doi-asserted-by":"publisher","first-page":"e0188120","DOI":"10.1371\/journal.pone.0188120","volume":"12","author":"X Moisset","year":"2017","unstructured":"Moisset X, Peri\u00e9 M, Pereira B, Dumont E, Lebrun-Frenay C, Lesage FX, Dutheil F, Taithe F, Clavelou P (2017) Decreased prevalence of cancer in patients with multiple sclerosis: a case-control study. PLoS ONE 12:e0188120. https:\/\/doi.org\/10.1371\/journal.pone.0188120","journal-title":"PLoS ONE"},{"key":"6362_CR8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/j.1468-1331.2012.03668.x","volume":"19","author":"A Lalmohamed","year":"2012","unstructured":"Lalmohamed A, Bazelier M, Van Staa T, Uitdehaag BM, Leufkens HG, De Boer A, De Vries F (2012) Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study. Eur J Neurol 19:1007\u20131014. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03668.x","journal-title":"Eur J Neurol"},{"key":"6362_CR9","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s00415-014-7370-3","volume":"261","author":"S Jick","year":"2014","unstructured":"Jick S, Li L, Falcone G, Vassilev Z, Wallander M-A (2014) Mortality of patients with multiple sclerosis: a cohort study in UK primary care. J Neurol 261:1508\u20131517. https:\/\/doi.org\/10.1007\/s00415-014-7370-3","journal-title":"J Neurol"},{"key":"6362_CR10","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1212\/01.wnl.0000345366.10455.62","volume":"72","author":"S Bahmanyar","year":"2009","unstructured":"Bahmanyar S, Montgomery SM, Hillert J, Ekbom A, Olsson T (2009) Cancer risk among patients with multiple sclerosis and their parents. Neurology 72:1170\u20131177. https:\/\/doi.org\/10.1212\/01.wnl.0000345366.10455.62","journal-title":"Neurology"},{"key":"6362_CR11","doi-asserted-by":"publisher","first-page":"102650","DOI":"10.1016\/j.autrev.2020.102650","volume":"19","author":"M Ghajarzadeh","year":"2020","unstructured":"Ghajarzadeh M, Mohammadi A, Sahraian MA (2020) Risk of cancer in multiple sclerosis (MS): a systematic review and meta-analysis. Autoimmun Rev 19:102650. https:\/\/doi.org\/10.1016\/j.autrev.2020.102650","journal-title":"Autoimmun Rev"},{"key":"6362_CR12","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/jnnp-2013-307238","volume":"85","author":"E Kingwell","year":"2014","unstructured":"Kingwell E, Evans C, Zhu F, Oger J, Hashimoto S, Tremlett H (2014) Assessment of cancer risk with \u03b2-interferon treatment for multiple sclerosis. J Neurol Neurosurg Psychiatry 85:1096\u20131102. https:\/\/doi.org\/10.1136\/jnnp-2013-307238","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6362_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12883-017-0932-0","volume":"17","author":"P Ragonese","year":"2017","unstructured":"Ragonese P, Aridon P, Vazzoler G, Mazzola MA, Lo Re V, Lo Re M, Realmuto S, Alessi S, D\u2019Amelio M, Savettieri G, Salemi G (2017) Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study. BMC Neurol 17:155. https:\/\/doi.org\/10.1186\/s12883-017-0932-0","journal-title":"BMC Neurol"},{"key":"6362_CR14","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s00415-011-5929-9","volume":"258","author":"C Lebrun","year":"2011","unstructured":"Lebrun C, Vermersch P, Brassat D, Defer G, Rumbach L, Clavelou P, Debouverie M, de Seze J, Wiertlevsky S, Heinzlef O, Tourbah A, Fromont A, Frenay M (2011) Cancer and multiple sclerosis in the era of disease-modifying treatments. J Neurol 258:1304\u20131311. https:\/\/doi.org\/10.1007\/s00415-011-5929-9","journal-title":"J Neurol"},{"key":"6362_CR15","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/ene.12710","volume":"22","author":"H Roshanisefat","year":"2015","unstructured":"Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S (2015) All-cause mortality following a cancer diagnosis amongst multiple sclerosis patients: a Swedish population-based cohort study. Eur J Neurol 22:1074\u20131080. https:\/\/doi.org\/10.1111\/ene.12710","journal-title":"Eur J Neurol"},{"key":"6362_CR16","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.3389\/fimmu.2019.02954","volume":"10","author":"E Melamed","year":"2020","unstructured":"Melamed E, Lee MW (2020) Multiple sclerosis and cancer: the Ying-Yang effect of disease modifying therapies. Front Immunol 10:2954. https:\/\/doi.org\/10.3389\/fimmu.2019.02954","journal-title":"Front Immunol"},{"key":"6362_CR17","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s10072-020-04727-5","volume":"42","author":"GD Maric","year":"2021","unstructured":"Maric GD, Pekmezovic TD, Mesaros ST, Tamas OS, Ivanovic JB, Martinovic VN, Andabaka MM, Jovanovic AL, Veselinovic ND, Kisic-Tepavcevic DB, Drulovic JS (2021) The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data. Neurol Sci 42:1887\u20131893. https:\/\/doi.org\/10.1007\/s10072-020-04727-5","journal-title":"Neurol Sci"},{"key":"6362_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452. https:\/\/doi.org\/10.1212\/wnl.33.11.1444","journal-title":"Neurology"},{"key":"6362_CR19","unstructured":"Serbian cancer registry. Malignant tumors in the Republic of Serbia (2019)\u00a0Institute of Public Health of Serbia \u201cDr Milan Jovanovi\u0107 Batut\u201d, 2021. Available at: https:\/\/www.batut.org.rs\/download\/publikacije\/maligniTumoriURepubliciSrbiji2019.pdf"},{"key":"6362_CR20","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1093\/brain\/aws148","volume":"135","author":"E Kingwell","year":"2012","unstructured":"Kingwell E, Bajdik C, Phillips N, Zhu F, Oger J, Hashimoto S, Tremlett H (2012) Cancer risk in multiple sclerosis: findings from British Columbia, Canada. Brain 135:2973\u20132979. https:\/\/doi.org\/10.1093\/brain\/aws148","journal-title":"Brain"},{"issue":"12 Suppl 5","key":"6362_CR21","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/s0003-9993(97)90220-3","volume":"78","author":"MA Nosek","year":"1997","unstructured":"Nosek MA, Howland CA (1997) Breast and cervical cancer screening among women with physical disabilities. Arch Phys Med Rehabil 78(12 Suppl 5):S39\u201344. https:\/\/doi.org\/10.1016\/s0003-9993(97)90220-3","journal-title":"Arch Phys Med Rehabil"},{"key":"6362_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.msard.2018.12.014","volume":"28","author":"M Norgaard","year":"2019","unstructured":"Norgaard M, Veres K, Didden EM, Wormser D, Magyari M (2019) Multiple sclerosis and cancer incidence: a Danish nationwide cohort study. Mult Scler Relat Disordx 28:81\u201385. https:\/\/doi.org\/10.1016\/j.msard.2018.12.014","journal-title":"Mult Scler Relat Disordx"},{"key":"6362_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.msard.2015.08.005","volume":"4","author":"G Capkun","year":"2015","unstructured":"Capkun G, Dahlke F, Lahoz R, Nordstrom B, Tilson HH, Cutter G, Bischof D, Moore A, Simeone J, Fraeman K, Bancken F, Geissb\u00fchler Y, Wagner M, Cohan S (2015) Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: an observational study using the US Department of Defense administrative claims database. Mult Scler Relat Disord 4:546\u2013554. https:\/\/doi.org\/10.1016\/j.msard.2015.08.005","journal-title":"Mult Scler Relat Disord"},{"key":"6362_CR24","doi-asserted-by":"publisher","first-page":"103209","DOI":"10.1016\/j.msard.2021.103209","volume":"55","author":"N Grytten","year":"2021","unstructured":"Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman MT, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen \u00d8 (2021) Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study. Mult Scler Relat Disord 55:103209. https:\/\/doi.org\/10.1016\/j.msard.2021.103209","journal-title":"Mult Scler Relat Disord"},{"key":"6362_CR25","doi-asserted-by":"publisher","first-page":"102691","DOI":"10.1016\/j.msard.2020.102691","volume":"48","author":"E Benjaminsen","year":"2021","unstructured":"Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB (2021) Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient Registry. Mult Scler Relat Disord 48:102691. https:\/\/doi.org\/10.1016\/j.msard.2020.102691","journal-title":"Mult Scler Relat Disord"},{"key":"6362_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/ene.12267","volume":"21","author":"LM Sun","year":"2014","unstructured":"Sun LM, Lin CL, Chung CJ, Liang JA, Sung FC, Kao CH (2014) Increased breast cancer risk for patients with multiple sclerosis: a nationwide population-based cohort study. Eur J Neurol 21:238\u2013244. https:\/\/doi.org\/10.1111\/ene.12267","journal-title":"Eur J Neurol"},{"issue":"3 Suppl 1","key":"6362_CR27","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","volume":"46","author":"MC White","year":"2014","unstructured":"White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ (2014) Age and cancer risk: a potentially modifiable relationship. Am J Prev Med 46(3 Suppl 1):S7\u201315. https:\/\/doi.org\/10.1016\/j.amepre.2013.10.029","journal-title":"Am J Prev Med"},{"key":"6362_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41582-019-0183-3","volume":"15","author":"CB Vaughn","year":"2019","unstructured":"Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RHB, Zivadinov R, Weinstock-Guttman B (2019) Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol 15:329\u2013342. https:\/\/doi.org\/10.1038\/s41582-019-0183-3","journal-title":"Nat Rev Neurol"},{"key":"6362_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2298\/sarh0408209m","volume":"132","author":"S Mesaros","year":"2004","unstructured":"Mesaros S, Stojsavljevic N, Dujmovic I, Mandic E, Drulovic J (2004) Evaluation of the long term effect of mitoxantrone on neurological disability in patients with active multiple sclerosis. Srp Arh Celok Lek 132:209\u2013213. https:\/\/doi.org\/10.2298\/sarh0408209m","journal-title":"Srp Arh Celok Lek"},{"key":"6362_CR30","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1212\/WNL.0b013e3181dc1ae0","volume":"74","author":"JJ Marriott","year":"2010","unstructured":"Marriott JJ, Miyasaki JM, Gronseth G, O\u2019Connor PW (2010) Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Evidence report: the efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 74:1463\u201370. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dc1ae0","journal-title":"Neurology"},{"key":"6362_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.biopha.2011.10.004","volume":"66","author":"N Colovic","year":"2012","unstructured":"Colovic N, Suvajdzic N, Kraguljac Kurtovic N, Djordjevic V, Dencic Fekete M, Drulovic J, Vidovic A, Tomin D (2012) Therapy-related acute leukemia in two patients with multiple sclerosis treated with mitoxantrone. Biomed Pharmacother 66:173\u2013174. https:\/\/doi.org\/10.1016\/j.biopha.2011.10.004","journal-title":"Biomed Pharmacother"},{"key":"6362_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","volume":"90","author":"A Rae-Grant","year":"2018","unstructured":"Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T (2018) Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 90:777\u2013788. https:\/\/doi.org\/10.1212\/WNL.0000000000005347","journal-title":"Neurology"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06362-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06362-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06362-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T12:12:52Z","timestamp":1668427972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06362-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6362"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06362-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"assertion":[{"value":"12 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Ethics Committee of the Faculty of Medicine, University of Belgrade (no. 29\/III-17).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}